Global Bio-pharma Market Research Report 2019

Table of Contents

Executive Summary

1 Bio-pharma Market Overview

• 1.1 Product Overview and Scope of Bio-pharma
• 1.2 Bio-pharma Segment by Type
  • 1.2.1 Global Bio-pharma Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Recombinant Proteins
  • 1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)
  • 1.2.5 Interferons
  • 1.2.6 Recombinant Human Insulin
  • 1.2.7 Erythropoietin
  • 1.2.8 Vaccines
  • 1.2.9 Growth Hormones
  • 1.2.10 Purified Proteins
  • 1.2.11 Others
• 1.3 Bio-pharma Segment by Application
  • 1.3.1 Bio-pharma Consumption Comparison by Application (2014-2025)
  • 1.3.2 Metabolic Disorders
  • 1.3.3 Oncology
  • 1.3.4 Neurological Disorders
  • 1.3.5 Cardiovascular Diseases
  • 1.3.6 Inflammatory and Infectious Diseases
  • 1.3.7 Others
• 1.3 Global Bio-pharma Market by Region
  • 1.3.1 Global Bio-pharma Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Bio-pharma Market Size
  • 1.4.1 Global Bio-pharma Revenue (2014-2025)
  • 1.4.2 Global Bio-pharma Production (2014-2025)

2 Global Bio-pharma Market Competition by Manufacturers

• 2.1 Global Bio-pharma Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Bio-pharma Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Bio-pharma Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Bio-pharma Production Sites, Area Served, Product Types
• 2.5 Bio-pharma Market Competitive Situation and Trends
  • 2.5.1 Bio-pharma Market Concentration Rate
  • 2.5.2 Bio-pharma Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Bio-pharma Production Market Share by Regions

• 3.1 Global Bio-pharma Production Market Share by Regions
• 3.2 Global Bio-pharma Revenue Market Share by Regions (2014-2019)
• 3.3 Global Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Bio-pharma Production
  • 3.4.1 North America Bio-pharma Production Growth Rate (2014-2019)
  • 3.4.2 North America Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Bio-pharma Production
  • 3.5.1 Europe Bio-pharma Production Growth Rate (2014-2019)
  • 3.5.2 Europe Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Bio-pharma Production (2014-2019)
  • 3.6.1 China Bio-pharma Production Growth Rate (2014-2019)
  • 3.6.2 China Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Bio-pharma Production (2014-2019)
  • 3.7.1 Japan Bio-pharma Production Growth Rate (2014-2019)
  • 3.7.2 Japan Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Bio-pharma Consumption by Regions

• 4.1 Global Bio-pharma Consumption by Regions
• 4.2 North America Bio-pharma Consumption (2014-2019)
• 4.3 Europe Bio-pharma Consumption (2014-2019)
• 4.4 China Bio-pharma Consumption (2014-2019)
• 4.5 Japan Bio-pharma Consumption (2014-2019)

5 Global Bio-pharma Production, Revenue, Price Trend by Type

• 5.1 Global Bio-pharma Production Market Share by Type (2014-2019)
• 5.2 Global Bio-pharma Revenue Market Share by Type (2014-2019)
• 5.3 Global Bio-pharma Price by Type (2014-2019)
• 5.4 Global Bio-pharma Production Growth by Type (2014-2019)

6 Global Bio-pharma Market Analysis by Applications

• 6.1 Global Bio-pharma Consumption Market Share by Application (2014-2019)
• 6.2 Global Bio-pharma Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Bio-pharma Business

• 7.1 Pfizer
  • 7.1.1 Pfizer Bio-pharma Production Sites and Area Served
  • 7.1.2 Bio-pharma Product Introduction, Application and Specification
  • 7.1.3 Pfizer Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 F. Hoffmann-La Roche AG
  • 7.2.1 F. Hoffmann-La Roche AG Bio-pharma Production Sites and Area Served
  • 7.2.2 Bio-pharma Product Introduction, Application and Specification
  • 7.2.3 F. Hoffmann-La Roche AG Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Johnson & Johnson Services
  • 7.3.1 Johnson & Johnson Services Bio-pharma Production Sites and Area Served
  • 7.3.2 Bio-pharma Product Introduction, Application and Specification
  • 7.3.3 Johnson & Johnson Services Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Sanofi, Amgen
  • 7.4.1 Sanofi, Amgen Bio-pharma Production Sites and Area Served
  • 7.4.2 Bio-pharma Product Introduction, Application and Specification
  • 7.4.3 Sanofi, Amgen Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 AbbVie
  • 7.5.1 AbbVie Bio-pharma Production Sites and Area Served
  • 7.5.2 Bio-pharma Product Introduction, Application and Specification
  • 7.5.3 AbbVie Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Merck & Co., Inc
  • 7.6.1 Merck & Co., Inc Bio-pharma Production Sites and Area Served
  • 7.6.2 Bio-pharma Product Introduction, Application and Specification
  • 7.6.3 Merck & Co., Inc Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Biogen Idec
  • 7.7.1 Biogen Idec Bio-pharma Production Sites and Area Served
  • 7.7.2 Bio-pharma Product Introduction, Application and Specification
  • 7.7.3 Biogen Idec Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Bayer AG
  • 7.8.1 Bayer AG Bio-pharma Production Sites and Area Served
  • 7.8.2 Bio-pharma Product Introduction, Application and Specification
  • 7.8.3 Bayer AG Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Eli Lilly and Company
  • 7.9.1 Eli Lilly and Company Bio-pharma Production Sites and Area Served
  • 7.9.2 Bio-pharma Product Introduction, Application and Specification
  • 7.9.3 Eli Lilly and Company Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Novartis AG GlaxoSmithKline Plc
  • 7.10.1 Novartis AG GlaxoSmithKline Plc Bio-pharma Production Sites and Area Served
  • 7.10.2 Bio-pharma Product Introduction, Application and Specification
  • 7.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Bristol-Myers Squibb Company
• 7.12 AstraZeneca PLC
• 7.13 Abbott Laboratories

8 Bio-pharma Manufacturing Cost Analysis

• 8.1 Bio-pharma Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Bio-pharma
• 8.4 Bio-pharma Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Bio-pharma Distributors List
• 9.3 Bio-pharma Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Bio-pharma Market Forecast

• 11.1 Global Bio-pharma Production, Revenue Forecast
  • 11.1.1 Global Bio-pharma Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Bio-pharma Price and Trend Forecast (2019-2025)
• 11.2 Global Bio-pharma Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Bio-pharma Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Bio-pharma Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Bio-pharma Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Bio-pharma Production, Revenue Forecast (2019-2025)
• 11.3 Global Bio-pharma Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Bio-pharma Consumption Forecast (2019-2025)
  • 11.3.2 Europe Bio-pharma Consumption Forecast (2019-2025)
  • 11.3.3 China Bio-pharma Consumption Forecast (2019-2025)
  • 11.3.4 Japan Bio-pharma Consumption Forecast (2019-2025)
• 11.4 Global Bio-pharma Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Bio-pharma Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List